drugset / Trial / NCT02557789
Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects
RandomizedCrossoverOpen-label
Summary
A Phase 1 study to assess the bioavailability and pharmacokinetics of a 600 mg immediate release tablet formulation of lefamulin when administered to fed and fasted healthy subjects in comparison to an intravenous formulation and a capsule formulation.
Timeline
- Start
- 2015-06
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lefamulin | Other / unclassified | 150 mg | Oral |
| Subject | Lefamulin | Other / unclassified | 600 mg | Oral |
Indications
No indication recorded.